 |
 |

General Cognitive Ability Following Unilateral and Bilateral Fetal Ventral Mesencephalic Tissue Transplantation for Treatment of Parkinson's Disease
Kimberlee J. Sass, PhD;
Cathleen P. Buchanan;
Michael Westerveld, PhD;
Kenneth L. Marek, MD;
Anita Farhi, RN;
Richard J. Robbins, MD;
Frederick Naftolin, MD, DPhil;
Timothy L. Vollmer, MD;
Csaba Leranth, MD, PhD;
Robert H. Roth, PhD;
Lawrence H. Price, MD;
Benjamin S. Bunney, MD;
John D. Elsworth, PhD;
Paul B. Hoffer, MD;
D. Eugene Redmond, MD;
Dennis D. Spencer, MD
Arch Neurol. 1995;52(7):680-686.
Abstract
 |  |
Objective To contrast the neuropsychological profiles of Parkinsonian patients, before and after fetal ventral mesencephalic tissue transplantation.
Design Case series of personally examined patients.
Setting Patients were evaluated by neurologists, neurosurgeons, and neuropsychologists as outpatients at a university hospital.
Patients Fetal mesencephalic tissue was implanted in the right caudate nucleus of three patients and both nuclei of one patient. These patients were evaluated prior to surgery and at 12, 24, and 26 months postoperatively.
Results Factor analysis of the test battery identified four statistically orthogonal test clusters. No statistically significant changes were identified postoperatively for clusters assessing verbal cognitive ability, nonverbal cognitive ability, and information-processing speed. An improvement of verbal memory cluster index was observed 12 months after surgery, and the improvement reached the level of statistical significance at 24 months after surgery. However, the verbal memory of all patients declined between 24 and 36 months after surgery.
Conclusions Fetal tissue transplantation to one or both caudate nuclei did not permanently arrest cognitive dysfunction. Although there is some evidence of improved cognitive ability after transplantation, it is improbable that normal cognitive function can be restored by this procedure because the impairments of cognitive ability associated with Parkinson's disease do not appear to originate solely from dopamine deficiency.
Author Affiliations
From the Yale Neural Transplant Program, Yale University School of Medicine, New Haven, Conn.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Between truth and hope: on Parkinson's disease, neurotransplantation and the production of the 'self'
Moreira and Palladino
History of the Human Sciences 2005;18:55-82.
ABSTRACT
Cognition following bilateral implants of embryonic dopamine neurons in PD: A double blind study
Trott et al.
Neurology 2003;60:1938-1943.
ABSTRACT
| FULL TEXT
Evaluation of surgery for Parkinson's disease: A Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Hallett and Litvan
Neurology 1999;53:1910-1910.
FULL TEXT
|